Seminars in Hematology
Volume 41, Issue 1 , Pages 83-89, January 2004

Severe ADAMTS-13 deficiency in childhood

  • Reinhard Schneppenheim

      Affiliations

    • Corresponding Author InformationAddress correspondence to Reinhard Schneppenheim, MD, PhD, University Hospital Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistrasse 52, D-20246 Hamburg, Germany
    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • ,
  • Ulrich Budde

      Affiliations

    • Lab Association Prof. Arndt and Partners, Coagulation Laboratory, Hamburg, Germany
  • ,
  • Wolf Hassenpflug

      Affiliations

    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • ,
  • Tobias Obser

      Affiliations

    • Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Abstract 

Thrombotic thrombocytopenic purpura (TTP) is a rare microangiopathic disorder with high morbidity and significant mortality. The primary form of TTP is caused by severe deficiency, acquired or hereditary, of the von Willebrand factor cleaving protease (VWF-CP), ADAMTS-13. Because TTP occurs less frequently in children, general pediatricians are not well informed about the spectrum of clinical symptoms and altered laboratory values, increasing the risk of nondiagnosis and possible fatal outcome. If renal involvement is present, the condition can easily be misdiagnosed as hemolytic-uremic syndrome (HUS). We present a case series of children with severe VWF-CP deficiency with emphasis on the clinical heterogeneity responsible for misdiagnosis and inappropriate treatment. The inherited form may involve onset of symptoms ranging from isolated thrombocytopenia to the full clinical picture characteristic of classical TTP. The most common assumed diagnoses of oligosymptomatic forms are immune thrombocytopenia (ITP) and Evans syndrome, respectively. Accordingly, this article is directed towards pediatricians on neonatal and intensive care units, as well as their colleagues specializing in nephrology, hematology, and neurology.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0037-1963(03)00273-7

doi:10.1053/j.seminhematol.2003.10.007

Seminars in Hematology
Volume 41, Issue 1 , Pages 83-89, January 2004